The SEC charged a medical device company and its founder with making false statements about a FDA approval for a key product.
The SEC charged a medical device company and its founder with making false statements about a FDA approval for a key product.
The FDA Chemist alleged to have engaged in insider trading using proprietary information from agency computers pleaded guilty insider trading charges. Specifically, Cheng Yi Laing entered a guilty plea to one count of securities fraud and one count of making …